Literature DB >> 29395507

Understanding the patient experience of health care-associated infection: A qualitative systematic review.

Kay Currie1, Lynn Melone2, Sally Stewart2, Caroline King2, Arja Holopainen3, Alex M Clark4, Jacqui Reilly2.   

Abstract

BACKGROUND: The global burden of health care-associated infection (HAI) is well recognized; what is less well known is the impact HAI has on patients. To develop acceptable, effective interventions, greater understanding of patients' experience of HAI is needed. This qualitative systematic review sought to explore adult patients' experiences of common HAIs.
METHODS: Five databases were searched. Search terms were combined for qualitative research, HAI terms, and patient experience. Study selection was conducted by 2 researchers using prespecified criteria. Critical Appraisal Skills Programme quality appraisal tools were used. Internationally recognized Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were applied. The Noblit and Hare (1988) approach to meta-synthesis was adopted.
RESULTS: Seventeen studies (2001-2017) from 5 countries addressing 5 common types of HAI met the inclusion criteria. Four interrelated themes emerged: the continuum of physical and emotional responses, experiencing the response of health care professionals, adapting to life with an HAI, and the complex cultural context of HAI.
CONCLUSIONS: The impact of different HAIs may vary; however, there are many similarities in the experience recounted by patients. The biosociocultural context of contagion was graphically expressed, with potential impact on social relationships and professional interactions highlighted. Further research to investigate contemporary patient experience in an era of antimicrobial resistance is warranted.
Copyright © 2018 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Health care–associated infection; Meta-synthesis; Patient's experience; Systematic review

Mesh:

Year:  2018        PMID: 29395507     DOI: 10.1016/j.ajic.2017.11.023

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  6 in total

Review 1.  Cross-transmission in the Dental Office: Does This Make You Ill?

Authors:  C M C Volgenant; J J de Soet
Journal:  Curr Oral Health Rep       Date:  2018-10-25

2.  How do we evaluate the cost of nosocomial infection? The ECONI protocol: an incidence study with nested case-control evaluating cost and quality of life.

Authors:  Sally Stewart; Chris Robertson; Sarkis Manoukian; Lynne Haahr; Helen Mason; Agi McFarland; Stephanie Dancer; Brian Cook; Jacqui Reilly; Nicholas Graves
Journal:  BMJ Open       Date:  2019-06-19       Impact factor: 2.692

3.  Barriers and facilitators on hand hygiene and hydro-alcoholic solutions' use: representations of health professionals and prevention perspectives.

Authors:  Nicolas Calcagni; Anne-Gaëlle Venier; Raymond Nasso; Guillaume Broc; Eva Ardichen; Bruno Jarrige; Pierre Parneix; Bruno Quintard
Journal:  Infect Prev Pract       Date:  2021-08-14

4.  Economic burden attributable to healthcare-associated infections in tertiary public hospitals of Central China: a multi-centre case-control study.

Authors:  Peng Li; Yan Li; Youjian Zhang; Junzhe Bao; Ruixia Yuan; Hongwen Lan; Mingjie Sun
Journal:  Epidemiol Infect       Date:  2022-08-15       Impact factor: 4.434

5.  Communicating treatment risks and benefits to cancer patients: a systematic review of communication methods.

Authors:  L F van de Water; J J van Kleef; W P M Dijksterhuis; I Henselmans; H G van den Boorn; N M Vaarzon Morel; K F Schut; J G Daams; E M A Smets; H W M van Laarhoven
Journal:  Qual Life Res       Date:  2020-04-24       Impact factor: 4.147

6.  Modelling the annual NHS costs and outcomes attributable to healthcare-associated infections in England.

Authors:  Julian F Guest; Tomas Keating; Dinah Gould; Neil Wigglesworth
Journal:  BMJ Open       Date:  2020-01-22       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.